Onkure Therapeutics Inc. Class AOKUR
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 42 institutions reported holding Onkure Therapeutics Inc. Class A (OKUR) in their 13F filings, down 7 from Q2 2025. 1 opened new positions and 8 sold out. The largest holders were Acorn Capital Advisors, LLC ($7.8M), Citadel Advisors ($2.8M) and Shay Capital LLC ($2.5M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Onkure Therapeutics Inc. Class A
- CUSIP
- 68277Q105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $138 |
| Exits | 8 | $1.6M |
All 13F filers, Q2 2025 → Q3 2025: 466,342 shares bought and 1,025,846 shares sold, net −559,504 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 42 holders
| Acorn Capital Advisors, LLC | 3.96% | No change | 2,839,674 | $7.8M |
| Citadel Advisors | 0.00% | Reduce -6.7% | 1,016,613 | $2.8M |
| Shay Capital LLC | 0.46% | Add +17.4% | 917,934 | $2.5M |
| Vanguard Group Inc. | 0.00% | Reduce -4.0% | 678,226 | $1.9M |
| Highbridge Capital Management LLC | 0.26% | Reduce -2.0% | 650,218 | $1.8M |
| Vestal Point Capital, LP | 0.08% | No change | 635,000 | $1.7M |
| BlackRock, Inc. | 0.00% | Add +0.0% | 564,836 | $1.6M |
| StepStone Group LP | 0.67% | No change | 491,938 | $1.4M |
| Cantor Fitzgerald, L. P. | 0.03% | Reduce -26.5% | 491,863 | $1.4M |
| NEA Management Company, LLC | 0.07% | No change | 478,548 | $1.3M |
| Carlyle Group Inc. | 0.02% | No change | 269,895 | $742K |
| Prosight Management, LP | 0.18% | Add +67.8% | 267,959 | $737K |
| Renaissance Technologies | 0.00% | Add +43.3% | 175,750 | $483K |
| Rangeley Capital, LLC | 0.41% | Add +420.0% | 155,490 | $428K |
| Tang Capital Management LLC | 0.01% | Reduce -31.2% | 116,395 | $320K |
| Aisling Capital Management LP | 0.05% | No change | 88,607 | $244K |
| Geode Capital Management, LLC | 0.00% | No change | 84,895 | $233K |
| Sphera Funds Management LTD. | 0.04% | No change | 60,454 | $166K |
| Gsa Capital Partners LLP | 0.01% | Add +172.1% | 59,224 | $163K |
| Aldebaran Capital, LLC | 0.11% | Reduce -0.4% | 43,997 | $121K |
| Two Sigma Advisers, LP | 0.00% | Reduce -0.8% | 26,608 | $73K |
| Two Sigma Investments, LP | 0.00% | Reduce -1.6% | 25,435 | $70K |
| Northern Trust Corp. | 0.00% | No change | 22,510 | $62K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -22.0% | 19,500 | $54K |
| Morgan Stanley | 0.00% | Add +3.1% | 17,214 | $47K |
| Wells Fargo & Company | 0.00% | Add +24.7% | 9,500 | $26K |
| Citigroup Inc. | 0.00% | Add +1224.3% | 3,324 | $9K |
| China Universal Asset Management Co., Ltd. | 0.00% | Reduce -12.6% | 2,251 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +5.6% | 1,935 | $5K |
| Bank of America Corp. | 0.00% | Add +5.7% | 896 | $2K |
| Barclays PLC | 0.00% | Reduce -37.6% | 621 | $2K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +0.4% | 497 | $1K |
| JPMorgan Chase & Co. | 0.00% | Add +174.7% | 423 | $1K |
| BNP Paribas Financial Markets | 0.00% | Add +9.3% | 364 | $1K |
| Royal Bank of Canada | 0.00% | Reduce -23.1% | 190 | $1K |
| GF Fund Management Co. LTD. | 0.00% | Reduce -13.4% | 271 | $745 |
| UBS Group AG | 0.00% | Add +13.3% | 205 | $564 |
| Trust Co. of Toledo NA | 0.00% | No change | 136 | $374 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $275 |
| Group One Trading LLC | 0.00% | No change | 56 | $154 |
| FMR LLC | 0.00% | New | 50 | $138 |
| MAI Capital Management | 0.00% | No change | 6 | $17 |
"% of holder's portfolio" is OKUR's weight in each manager's 13F, not the share of Onkure Therapeutics Inc. Class A the manager owns.